Akèy › Kansè bronch › Michigan
Etid klinik pou Kansè bronch nan Michigan
5 etid pou Kansè bronch ap chèche patisipan nan sit nan Michigan.
Tèks ofisyèl etid la (Anglè)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Michigan, Ann Arbor
- The Cancer & Hematology Centers, Grand Rapids
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Henry Ford Cancer Institute, Detroit
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 26, 2026 · NCT04614103Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.